Market Analysis and Insights: Global Small Molecule Targeted Therapy Market
The global Small Molecule Targeted Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Small Molecule Targeted Therapy market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Small Molecule Targeted Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Small Molecule Targeted Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Small Molecule Targeted Therapy revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Small Molecule Targeted Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Small Molecule Targeted Therapy revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
Segment by Type
TKI
Multitarget Inhibitor
Others
Segment by Application
Liver Cancer
Colorectal Cancer
Lung Cancer
Gastric Cancer
Breast Cancer
Esophageal Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Small Molecule Targeted Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Small Molecule Targeted Therapy companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Small Molecule Targeted Therapy revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 TKI
1.2.3 Multitarget Inhibitor
1.2.4 Others
1.3 Market by Application
1.3.1 Global Small Molecule Targeted Therapy Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Liver Cancer
1.3.3 Colorectal Cancer
1.3.4 Lung Cancer
1.3.5 Gastric Cancer
1.3.6 Breast Cancer
1.3.7 Esophageal Cancer
1.3.8 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Targeted Therapy Market Perspective (2019-2030)
2.2 Global Small Molecule Targeted Therapy Growth Trends by Region
2.2.1 Small Molecule Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Small Molecule Targeted Therapy Historic Market Size by Region (2019-2024)
2.2.3 Small Molecule Targeted Therapy Forecasted Market Size by Region (2025-2030)
2.3 Small Molecule Targeted Therapy Market Dynamics
2.3.1 Small Molecule Targeted Therapy Industry Trends
2.3.2 Small Molecule Targeted Therapy Market Drivers
2.3.3 Small Molecule Targeted Therapy Market Challenges
2.3.4 Small Molecule Targeted Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Small Molecule Targeted Therapy by Players
3.1.1 Global Small Molecule Targeted Therapy Revenue by Players (2019-2024)
3.1.2 Global Small Molecule Targeted Therapy Revenue Market Share by Players (2019-2024)
3.2 Global Small Molecule Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Small Molecule Targeted Therapy, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Small Molecule Targeted Therapy Market Concentration Ratio
3.4.1 Global Small Molecule Targeted Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Targeted Therapy Revenue in 2023
3.5 Global Key Players of Small Molecule Targeted Therapy Head office and Area Served
3.6 Global Key Players of Small Molecule Targeted Therapy, Product and Application
3.7 Global Key Players of Small Molecule Targeted Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Targeted Therapy Breakdown Data by Type
4.1 Global Small Molecule Targeted Therapy Historic Market Size by Type (2019-2024)
4.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Type (2025-2030)
5 Small Molecule Targeted Therapy Breakdown Data by Application
5.1 Global Small Molecule Targeted Therapy Historic Market Size by Application (2019-2024)
5.2 Global Small Molecule Targeted Therapy Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Small Molecule Targeted Therapy Market Size (2019-2030)
6.2 North America Small Molecule Targeted Therapy Market Size by Type
6.2.1 North America Small Molecule Targeted Therapy Market Size by Type (2019-2024)
6.2.2 North America Small Molecule Targeted Therapy Market Size by Type (2025-2030)
6.2.3 North America Small Molecule Targeted Therapy Market Share by Type (2019-2030)
6.3 North America Small Molecule Targeted Therapy Market Size by Application
6.3.1 North America Small Molecule Targeted Therapy Market Size by Application (2019-2024)
6.3.2 North America Small Molecule Targeted Therapy Market Size by Application (2025-2030)
6.3.3 North America Small Molecule Targeted Therapy Market Share by Application (2019-2030)
6.4 North America Small Molecule Targeted Therapy Market Size by Country
6.4.1 North America Small Molecule Targeted Therapy Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Small Molecule Targeted Therapy Market Size by Country (2019-2024)
6.4.3 North America Small Molecule Targeted Therapy Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Small Molecule Targeted Therapy Market Size (2019-2030)
7.2 Europe Small Molecule Targeted Therapy Market Size by Type
7.2.1 Europe Small Molecule Targeted Therapy Market Size by Type (2019-2024)
7.2.2 Europe Small Molecule Targeted Therapy Market Size by Type (2025-2030)
7.2.3 Europe Small Molecule Targeted Therapy Market Share by Type (2019-2030)
7.3 Europe Small Molecule Targeted Therapy Market Size by Application
7.3.1 Europe Small Molecule Targeted Therapy Market Size by Application (2019-2024)
7.3.2 Europe Small Molecule Targeted Therapy Market Size by Application (2025-2030)
7.3.3 Europe Small Molecule Targeted Therapy Market Share by Application (2019-2030)
7.4 Europe Small Molecule Targeted Therapy Market Size by Country
7.4.1 Europe Small Molecule Targeted Therapy Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Small Molecule Targeted Therapy Market Size by Country (2019-2024)
7.4.3 Europe Small Molecule Targeted Therapy Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Small Molecule Targeted Therapy Market Size (2019-2030)
8.2 China Small Molecule Targeted Therapy Market Size by Type
8.2.1 China Small Molecule Targeted Therapy Market Size by Type (2019-2024)
8.2.2 China Small Molecule Targeted Therapy Market Size by Type (2025-2030)
8.2.3 China Small Molecule Targeted Therapy Market Share by Type (2019-2030)
8.3 China Small Molecule Targeted Therapy Market Size by Application
8.3.1 China Small Molecule Targeted Therapy Market Size by Application (2019-2024)
8.3.2 China Small Molecule Targeted Therapy Market Size by Application (2025-2030)
8.3.3 China Small Molecule Targeted Therapy Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Small Molecule Targeted Therapy Market Size (2019-2030)
9.2 Asia Small Molecule Targeted Therapy Market Size by Type
9.2.1 Asia Small Molecule Targeted Therapy Market Size by Type (2019-2024)
9.2.2 Asia Small Molecule Targeted Therapy Market Size by Type (2025-2030)
9.2.3 Asia Small Molecule Targeted Therapy Market Share by Type (2019-2030)
9.3 Asia Small Molecule Targeted Therapy Market Size by Application
9.3.1 Asia Small Molecule Targeted Therapy Market Size by Application (2019-2024)
9.3.2 Asia Small Molecule Targeted Therapy Market Size by Application (2025-2030)
9.3.3 Asia Small Molecule Targeted Therapy Market Share by Application (2019-2030)
9.4 Asia Small Molecule Targeted Therapy Market Size by Region
9.4.1 Asia Small Molecule Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Small Molecule Targeted Therapy Market Size by Region (2019-2024)
9.4.3 Asia Small Molecule Targeted Therapy Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Small Molecule Targeted Therapy Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Astrazeneca
11.1.1 Astrazeneca Company Details
11.1.2 Astrazeneca Business Overview
11.1.3 Astrazeneca Small Molecule Targeted Therapy Introduction
11.1.4 Astrazeneca Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.1.5 Astrazeneca Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Small Molecule Targeted Therapy Introduction
11.2.4 Novartis Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Millennium Pharmaceuticals
11.3.1 Millennium Pharmaceuticals Company Details
11.3.2 Millennium Pharmaceuticals Business Overview
11.3.3 Millennium Pharmaceuticals Small Molecule Targeted Therapy Introduction
11.3.4 Millennium Pharmaceuticals Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.3.5 Millennium Pharmaceuticals Recent Developments
11.4 Bayer
11.4.1 Bayer Company Details
11.4.2 Bayer Business Overview
11.4.3 Bayer Small Molecule Targeted Therapy Introduction
11.4.4 Bayer Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.4.5 Bayer Recent Developments
11.5 Exelixis
11.5.1 Exelixis Company Details
11.5.2 Exelixis Business Overview
11.5.3 Exelixis Small Molecule Targeted Therapy Introduction
11.5.4 Exelixis Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.5.5 Exelixis Recent Developments
11.6 Abbvie
11.6.1 Abbvie Company Details
11.6.2 Abbvie Business Overview
11.6.3 Abbvie Small Molecule Targeted Therapy Introduction
11.6.4 Abbvie Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.6.5 Abbvie Recent Developments
11.7 Boehringer-Ingelheim
11.7.1 Boehringer-Ingelheim Company Details
11.7.2 Boehringer-Ingelheim Business Overview
11.7.3 Boehringer-Ingelheim Small Molecule Targeted Therapy Introduction
11.7.4 Boehringer-Ingelheim Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.7.5 Boehringer-Ingelheim Recent Developments
11.8 Eisai
11.8.1 Eisai Company Details
11.8.2 Eisai Business Overview
11.8.3 Eisai Small Molecule Targeted Therapy Introduction
11.8.4 Eisai Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.8.5 Eisai Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Small Molecule Targeted Therapy Introduction
11.9.4 Pfizer Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.9.5 Pfizer Recent Developments
11.10 Bristol-Myers Squibb
11.10.1 Bristol-Myers Squibb Company Details
11.10.2 Bristol-Myers Squibb Business Overview
11.10.3 Bristol-Myers Squibb Small Molecule Targeted Therapy Introduction
11.10.4 Bristol-Myers Squibb Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.10.5 Bristol-Myers Squibb Recent Developments
11.11 Roche
11.11.1 Roche Company Details
11.11.2 Roche Business Overview
11.11.3 Roche Small Molecule Targeted Therapy Introduction
11.11.4 Roche Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.11.5 Roche Recent Developments
11.12 Bettapharma
11.12.1 Bettapharma Company Details
11.12.2 Bettapharma Business Overview
11.12.3 Bettapharma Small Molecule Targeted Therapy Introduction
11.12.4 Bettapharma Revenue in Small Molecule Targeted Therapy Business (2019-2024)
11.12.5 Bettapharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Astrazeneca
Novartis
Millennium Pharmaceuticals
Bayer
Exelixis
Abbvie
Boehringer-Ingelheim
Eisai
Pfizer
Bristol-Myers Squibb
Roche
Bettapharma
听
听
*If Applicable.
